Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.
about
Dynamic Contrast-Enhanced MRI to Study Atherosclerotic Plaque MicrovasculatureApoptotic cell clearance: basic biology and therapeutic potential.Anti-inflammatory therapy in chronic disease: challenges and opportunitiesImaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsDetection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CTImaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imagingThe role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases.Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbitsThe complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.Imaging macrophage development and fate in atherosclerosis and myocardial infarctionSmall animal positron emission tomography imaging and in vivo studies of atherosclerosis.Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.Nuclear Receptors and Clearance of Apoptotic Cells: Stimulating the Macrophage's Appetite.28-Homobrassinolide: a novel oxysterol transactivating LXR gene expression.Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification.Prix Fixe: Efferocytosis as a Four-Course Meal.Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.Neutrophils as protagonists and targets in chronic inflammation.SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries.Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques.Atherosclerotic plaque inflammation quantification using dynamic contrast-enhanced (DCE) MRI.Imaging the Permeable Endothelium: Predicting Plaque Rupture in Atherosclerotic Rabbits.Metabolism Controls the Balance of Th17/T-Regulatory Cells.Vessel wall characterization using quantitative MRI: what's in a number?Homologous HOmologous Black-Bright-blood and flexible Interleaved imaging sequence (HOBBI) for dynamic contrast-enhanced MRI of the vessel wall.Human Plasma Metabolomics Implicates Modified 9-cis-Retinoic Acid in the Phenotype of Left Main Artery Lesions in Acute ST-Segment Elevated Myocardial Infarction
P2860
Q26749689-B146E584-375F-4526-AE8B-1438CC63B528Q26825935-0D23C9A5-FE6C-471D-9241-52C191AA06B9Q26860162-CB3B6694-0650-4CC9-87E2-E140CBD5B93AQ34518372-90ABC47D-0A40-4AC6-89C2-8046DC7E5BFFQ34684088-329E32E0-65D4-45CA-965F-DCC1AD413DD5Q35072987-3D4B683D-184D-401A-99BC-918A4984AEBDQ36085086-A74F722A-710C-4C22-A002-8D9E085B3C36Q36412437-E3A0E17E-19F2-4B47-A6C6-08F063685557Q37296851-826529CF-A527-4314-AA9A-EF4F20015DD4Q38064660-82871A31-97CC-45CB-B9C2-0E2EAA399B1BQ38092246-EB82C298-81F2-4E76-AB24-74F8F73B00A3Q38094125-D07BFE23-B80A-4E00-91C6-C47226B012B7Q38214660-B564C41A-7E4C-4E62-A90F-02D4E02BBA2FQ38305258-194DA4D7-2ADD-4644-8330-6A68FDF45EB2Q38397910-3BC5E3D1-4E33-43A9-9231-900C8C976E95Q38573436-58A43891-30F5-453E-BF71-CA3CEDA20480Q38801539-5E6EE989-A1B7-47B2-977D-710DE293CB81Q39175804-D72287BE-2810-4E17-BE51-6EDFE6BC449EQ41238952-4EBF62FC-1E34-4D57-BE7D-699480902AAFQ41839877-536708AD-9475-42F1-A908-4B788B4F2A4CQ41854592-F613BAFF-9A0D-40EC-A7A5-064098EE9F9EQ46149579-0A57D63A-97F7-4FF3-AF03-0D69D719B0D8Q47118555-9A6373EB-4952-4F8C-9DF4-EA3B52F0818DQ47794497-63C90909-96BB-44F7-9934-E8A43A58EB75Q53556906-BAAC35F2-3063-401F-88B5-DD54E1FE4D56Q58699526-95AD0FD7-BBC1-429D-B68E-1884D987BA27
P2860
Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Regression of inflammation in ...... comparison with atorvastatin.
@en
type
label
Regression of inflammation in ...... comparison with atorvastatin.
@en
prefLabel
Regression of inflammation in ...... comparison with atorvastatin.
@en
P2093
P2860
P50
P1476
Regression of inflammation in ...... comparison with atorvastatin.
@en
P2093
Claudia Calcagno
Erin Moshier
Esad Vucic
James H F Rudd
Jan Bucerius
Jessica S Mounessa
Karen Brown
Katsumi Hayashi
Masakatsu Kotsuma
P2860
P304
P356
10.1016/J.JCMG.2011.11.025
P577
2012-08-01T00:00:00Z